Art

J-GLOBAL ID：200902142798252543   Reference number：00A0460647

Prospects for development of new antimycobacterial drugs.

新しい抗マイコバクテリア薬開発の展望

Author (1)： TOMIOKA H (Shimane Medical Univ., Shimane, JPN)
Material： Journal of Infection and Chemotherapy  (J Infect Chemother)
Volume： 6  Issue： 1  Page： 8-20  Publication year： Mar. 2000 
JST Material Number： L2852A  ISSN： 1341-321X  Document type： Article
Article type： 文献レビュー  Country of issue： United Kingdom (GBR)  Language： ENGLISH (EN)

Thesaurus term： *Mycobacterium avium ,...
Semi thesaurus term： bridged compound

   To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=00A0460647&from=J-GLOBAL&jstjournalNo=L2852A") }}

JST classification (2)： Basic research of antibacterial drugs  (GW17020S) ,  Basic research of antibiotics acting on pathogenic organisms  (GX05020C)

Substance index (10)： Ciprofloxacin ,  Ofloxacin ,  Sparfloxacin ,  Levofloxacin ,  Clarithromycin ,  Roxithromycin ,  Rifabutin ,  Rifapentine ,  Rifamycin ,  Azithromycin

Reference (148)：

• KOCHI, A. Multidrug-resistant tuberculosis and its control. Res Microbiol. 1993, 144, 104-110
• MCGOWAN, JE. Multiple-drug-resistant tuberculosis: clinical and laboratory issues. Res Microbiol. 1993, 144, 122-129
• RILEY, LW. Drug-resistant tuberculosis. Clin Infect Dis. 1993, 17, Suppl 2, S442-S446
• HART, CA. Tuberculosis into the next centry. J Med Microbiol. 1996, 44, 1-34
• COHN, DL. Treatment and prevention of multidrug-resistant tuberculosis. Res Microbiol. 1993, 144, 150-153

Terms in the title (3)： マイコバクテリア ,  開発 ,  展望